Diagnostic Medical Systems S.A. (ALDMS.PA)
EUR 0.68
(-2.57%)
EUR 0.68
(-2.57%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 11.52 Million EUR | 19.56% |
| 2022 | 9.64 Million EUR | -17.36% |
| 2021 | 11.66 Million EUR | -11.16% |
| 2020 | 13.13 Million EUR | 57.36% |
| 2019 | 8.34 Million EUR | -0.5% |
| 2018 | 8.38 Million EUR | 118.61% |
| 2017 | 3.83 Million EUR | 524.92% |
| 2016 | 614 Thousand EUR | -31.63% |
| 2015 | 898 Thousand EUR | 138.43% |
| 2014 | -2.33 Million EUR | -14.78% |
| 2013 | -2.03 Million EUR | -123.74% |
| 2012 | -910 Thousand EUR | -222.31% |
| 2011 | 744 Thousand EUR | 119.2% |
| 2010 | -3.87 Million EUR | -316.67% |
| 2009 | -930 Thousand EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 12.67 Million EUR | 0.0% |
| 2023 Q2 | 14.27 Million EUR | 4.43% |
| 2023 Q1 | 13.66 Million EUR | 41.74% |
| 2023 Q4 | 11.52 Million EUR | 201.39% |
| 2023 Q3 | 3.82 Million EUR | -73.2% |
| 2023 FY | 11.52 Million EUR | 19.56% |
| 2022 Q3 | 10.41 Million EUR | -17.9% |
| 2022 Q2 | 12.67 Million EUR | 5.22% |
| 2022 Q1 | 12.05 Million EUR | 3.28% |
| 2022 FY | 9.64 Million EUR | -17.36% |
| 2022 Q4 | 9.64 Million EUR | -7.38% |
| 2021 Q3 | 11.01 Million EUR | -20.19% |
| 2021 Q2 | 13.8 Million EUR | 2.51% |
| 2021 FY | 11.66 Million EUR | -11.16% |
| 2021 Q4 | 11.66 Million EUR | 5.89% |
| 2021 Q1 | 13.46 Million EUR | 2.54% |
| 2020 Q3 | 12.46 Million EUR | 147.97% |
| 2020 Q1 | 4.82 Million EUR | -42.19% |
| 2020 FY | 13.13 Million EUR | 57.36% |
| 2020 Q2 | 5.02 Million EUR | 4.17% |
| 2020 Q4 | 13.13 Million EUR | 5.38% |
| 2019 FY | 8.34 Million EUR | -0.5% |
| 2019 Q4 | 8.34 Million EUR | 2.97% |
| 2019 Q1 | 6.65 Million EUR | -20.64% |
| 2019 Q2 | 6.99 Million EUR | 5.11% |
| 2019 Q3 | 8.1 Million EUR | 15.84% |
| 2018 Q1 | 4.11 Million EUR | 7.14% |
| 2018 Q2 | 4.11 Million EUR | 0.0% |
| 2018 FY | 8.38 Million EUR | 118.61% |
| 2018 Q4 | 8.38 Million EUR | 50.65% |
| 2018 Q3 | 5.56 Million EUR | 35.44% |
| 2017 FY | 3.83 Million EUR | 524.92% |
| 2017 Q4 | 3.83 Million EUR | 133.11% |
| 2017 Q3 | 1.64 Million EUR | 172.9% |
| 2017 Q2 | -2.25 Million EUR | 1.31% |
| 2017 Q1 | -2.28 Million EUR | -472.64% |
| 2016 Q4 | 614 Thousand EUR | 131.75% |
| 2016 Q2 | -59 Thousand EUR | 33.71% |
| 2016 Q3 | -1.93 Million EUR | -3177.97% |
| 2016 Q1 | -89 Thousand EUR | -109.91% |
| 2016 FY | 614 Thousand EUR | -31.63% |
| 2015 Q4 | 898 Thousand EUR | 179.33% |
| 2015 FY | 898 Thousand EUR | 138.43% |
| 2015 Q3 | -1.13 Million EUR | -19.54% |
| 2015 Q2 | -947 Thousand EUR | 78.85% |
| 2015 Q1 | -4.47 Million EUR | -91.57% |
| 2014 FY | -2.33 Million EUR | -14.78% |
| 2014 Q4 | -2.33 Million EUR | 56.44% |
| 2014 Q3 | -5.36 Million EUR | -4026.92% |
| 2014 Q2 | -130 Thousand EUR | 0.0% |
| 2014 Q1 | -130 Thousand EUR | 93.61% |
| 2013 Q2 | -709 Thousand EUR | 41.65% |
| 2013 FY | -2.03 Million EUR | -123.74% |
| 2013 Q3 | -2.03 Million EUR | -187.17% |
| 2013 Q4 | -2.03 Million EUR | 0.0% |
| 2013 Q1 | -1.21 Million EUR | -33.52% |
| 2012 FY | -910 Thousand EUR | -222.31% |
| 2012 Q2 | -2.87 Million EUR | 0.0% |
| 2012 Q4 | -910 Thousand EUR | 0.0% |
| 2011 Q2 | -1.34 Million EUR | 0.0% |
| 2011 Q4 | 744 Thousand EUR | 0.0% |
| 2011 FY | 744 Thousand EUR | 119.2% |
| 2010 FY | -3.87 Million EUR | -316.67% |
| 2010 Q4 | -3.87 Million EUR | 0.0% |
| 2010 Q2 | 268 Thousand EUR | 0.0% |
| 2009 Q4 | -930 Thousand EUR | 0.0% |
| 2009 Q2 | -1.1 Million EUR | 0.0% |
| 2009 FY | -930 Thousand EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Affluent Medical SA | 15.47 Million EUR | 25.51% |
| Bluelinea Société Anonyme | -870.82 Thousand EUR | 1423.799% |
| Carmat SA | 49.63 Million EUR | 76.775% |
| Euromedis Groupe | -8.82 Million EUR | 230.612% |
| Eurobio Scientific Société anonyme | 51.33 Million EUR | 77.543% |
| Ikonisys S.A. | 3.19 Million EUR | -260.464% |
| Implanet S.A. | 5.9 Million EUR | -95.291% |
| Median Technologies SA | 3.5 Million EUR | -228.808% |
| SpineGuard SA | 215.79 Thousand EUR | -5242.058% |
| Theraclion SA | -5.86 Million EUR | 296.571% |
| Euroapi S.A. | 191 Million EUR | 93.964% |
| Guerbet SA | 332.59 Million EUR | 96.534% |
| Ion Beam Applications SA | -67.72 Million EUR | 117.022% |
| Koninklijke Philips N.V. | 5.82 Billion EUR | 99.802% |
| Sequana Medical NV | 14.2 Million EUR | 18.833% |